FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of…
Tag: obesity
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Novo Nordisk A/S won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a…
Eli Lilly, Novo Nordisk file competing new weight-loss drugs with the FDA that could be game changers in obesity medicine
Here’s how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound www.marketwatch.com #Eli #Lilly…
Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14,…
Obesity pills from Novo Nordisk, Eli Lilly are coming
Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…
WHO recommends GLP-1 for treating obesity. What is it?
The World Health Organisation on Monday conditionally recommended the use of GLP-1 therapies as part of long-term treatment for obesity,…
WHO warning over shortage of obesity jabs
Michelle RobertsDigital health editor Getty Images Fewer than one in 10 people who could benefit from obesity jabs like Wegovy…
Obesity drug semaglutide fails to slow Alzheimer’s
Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer’s –…
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients
Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to…
Novo Nordisk boosts the case for its obesity pill
A view shows a Novo Nordisk sign outside its office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on July…